‘A Significant Assault on Our Health’: Healthcare Policy Leaders Condemn Trump’s Budget Proposal
President Donald Trump’s 2027 budget proposes deep healthcare cuts, raising concerns about harm to patients and research.
President Donald Trump’s 2027 budget proposes deep healthcare cuts, raising concerns about harm to patients and research.
Healthcare leaders can’t tell whether value-based care and Medicare Advantage are truly lowering costs. Some see promise in these models and ongoing innovations, while others say the programs haven’t delivered measurable savings and point to direct contracting as a more transparent way to control spending.
Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems.
Employer groups praised a bill aimed at boosting healthcare competition and lowering costs by banning anticompetitive insurer-provider contracts.
Some healthcare experts supported Trump’s comments on lowering prescription drug costs, while others criticized his remarks on health coverage.
The Consolidated Appropriations Act of 2026 and the Department of Labor’s proposed rule implement major PBM reforms for employers, but don’t include everything they want, including a ban on spread pricing.
As lawmakers consider stricter PBM regulation, Cigna launched a “rebate-free” model to give patients upfront drug discounts, but experts question whether it will lead to meaningful change.
Many employers are struggling to access their medical claims data from vendors. However, those who do have access are more likely to implement strategies to combat healthcare costs.
Employers are advocating for changes to the 340B Drug Pricing Program, arguing that it allows hospitals to "buy low and sell high" by purchasing discounted medications and charging insured patients full price.
GLP-1s have proven to be highly effective for weight loss but pose significant cost challenges for employers, according to a recent panel of experts at MedCity INVEST.
In a webinar sponsored by Personify Health, executives from international chemical company Dow and the National Alliance of Healthcare Purchaser Coalitions discussed some of the tough choices companies are making.
Employers are starting to face lawsuits from employees for not fulfilling their fiduciary duty. However, employers are also struggling to access their claims data from their third party administrators, which makes it difficult to uphold their fiduciary responsibility, experts say.
Employers are in a unique position to drive change in obesity care, but face several challenges. Experts shared numerous strategies employers can implement.
Employers are struggling with point solution fatigue, but does that mean new startups shouldn't be selling to them anymore? Experts have mixed opinions.
The Payer Insights Program at ViVE 2024, in partnership with MedCity News, kicks off day one at the event. This new immersive program will focus on the impact of rising healthcare costs, recent regulatory changes, and innovative payer solutions for optimizing data insights, minimizing costs, and expanding access to care.
About eight in 10 employers think drug costs, high-cost claims and hospital prices are a “significant threat to affordability,” according to a new survey from National Alliance of Healthcare Purchaser Coalitions.